Abingdon Health Plc (AIM:ABDX)
London · Delayed Price · Currency is GBP · Price in GBX 6.25
-0.25 (-4.00%)
Jul 21, 2025, 4:35 PM GMT+1
Abingdon Health Company Description
Abingdon Health Plc operates as contract research, and contract development and manufacturing organization that develops, manufactures, and distributes diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally.
The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant health, and for nucleic acid detection.
Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.
Abingdon Health Plc
| Country | United Kingdom |
| Founded | 2008 |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Employees | 84 |
| CEO | Chris Henry Yates |
Contact Details
Address: York Biotech Campus York, YO41 1LZ United Kingdom | |
| Phone | 44 19 0440 6050 |
| Website | abingdonhealth.com |
Stock Details
| Ticker Symbol | ABDX |
| Exchange | London Stock Exchange AIM |
| Fiscal Year | July - June |
| Reporting Currency | GBP |
| ISIN Number | GB00BLF79J41 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Chris Henry Yates | Chief Executive Officer |
| Thomas Hayes | Chief Financial Officer |
| Mark Jones | Chief Operating Officer |